Lorazepam recalls

The FDA has published 14 recalls involving Lorazepam since 2017. The latest was reported on 6 Aug 2025. Most were for potency & assay. Hikma Pharmaceuticals USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls14since 2017

Last 12 months0reported

Class I17% of total

Ongoing6latest 6 Aug 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 3 0 0Apr 0 0 0Jul 1 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 7%Class II 13 93%Class III 0 0%

Why lorazepam is recalled

Companies

Brands

Lorazepam750%
Ativan17%

By year

2025429%
2023429%
2022429%
2017214%

Ongoing lorazepam recalls

6 active

Reported	Class	Recall	Company	Reason	Where
6 Aug 2025Drug	CLASS II	Lorazepam Injection, USP, 2 mg/mL, 25 x vials/carton recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
26 Feb 2025Drug	CLASS II	Lorazepam Tablets, USP, 2mg, Unit Dose per carton ( blister packs) recalled	The Harvard Drug Group	Potency & Assay	Nationwide
26 Feb 2025Drug	CLASS II	Lorazepam Tablets, USP, 1mg, Unit Dose per carton ( blister packs) recalled	The Harvard Drug Group	Potency & Assay	Nationwide
26 Feb 2025Drug	CLASS II	Lorazepam Tablets, USP, 5mg, Unit Dose per carton ( blister packs) recalled	The Harvard Drug Group	Potency & Assay	Nationwide
7 Jun 2023Drug	CLASS II	Lorazepam Oral Concentrate, USP, 2mg per mL recalled by Akorn	Akorn	Sterility	Nationwide
7 Jun 2023Drug	CLASS II	Lorazepam Injection, USP 2 mg/mL vial vials recalled by Akorn	Akorn	Sterility	Nationwide

All lorazepam recalls, newest first

14 total

Reported	Class	Recall	Company	Reason	Where
6 Aug 2025Drug	CLASS II	Lorazepam Injection, USP, 2 mg/mL, 25 x vials/carton recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
26 Feb 2025Drug	CLASS II	Lorazepam Tablets, USP, 2mg, Unit Dose per carton ( blister packs) recalled	The Harvard Drug Group	Potency & Assay	Nationwide
26 Feb 2025Drug	CLASS II	Lorazepam Tablets, USP, 1mg, Unit Dose per carton ( blister packs) recalled	The Harvard Drug Group	Potency & Assay	Nationwide
26 Feb 2025Drug	CLASS II	Lorazepam Tablets, USP, 5mg, Unit Dose per carton ( blister packs) recalled	The Harvard Drug Group	Potency & Assay	Nationwide
7 Jun 2023Drug	CLASS II	Lorazepam Oral Concentrate, USP, 2mg per mL recalled by Akorn	Akorn	Sterility	Nationwide
7 Jun 2023Drug	CLASS II	Lorazepam Injection, USP 2 mg/mL vial vials recalled by Akorn	Akorn	Sterility	Nationwide
24 May 2023Drug	CLASS II	Lorazepam Injection, USP, 2mg/mL vial recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
24 May 2023Drug	CLASS II	LORazepam Injection, 2mg / mL Single Dose vial vial recalled	RemedyRepack	Manufacturing (CGMP) Deviations	PA
17 Aug 2022Drug	CLASS II	Lorazepam Injection, USP, 2mg/mL vial, 25 vials recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
17 Aug 2022Drug	CLASS II	Lorazepam Injection, USP, 4mg/mL vial, 25 vial recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide

Should you stop taking Lorazepam?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.